Growth Metrics

Bio-Rad Laboratories (BIO) Long-Term Debt Repayments (2016 - 2026)

Bio-Rad Laboratories has reported Long-Term Debt Repayments over the past 18 years, most recently at $100000.0 for Q1 2026.

  • Quarterly Long-Term Debt Repayments changed 0.0% to $100000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $500000.0 through Mar 2026, up 66.67% year-over-year, with the annual reading at $500000.0 for FY2025, 25.0% up from the prior year.
  • Long-Term Debt Repayments was $100000.0 for Q1 2026 at Bio-Rad Laboratories, down from $200000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $200000.0 in Q1 2024 and troughed at $100000.0 in Q2 2024.
  • The 5-year median for Long-Term Debt Repayments is $116000.0 (2023), against an average of $133333.3.
  • Year-over-year, Long-Term Debt Repayments plummeted 92.58% in 2022 and then skyrocketed 100.0% in 2025.
  • A 5-year view of Long-Term Debt Repayments shows it stood at $133000.0 in 2022, then rose by 13.53% to $151000.0 in 2023, then tumbled by 33.77% to $100000.0 in 2024, then skyrocketed by 100.0% to $200000.0 in 2025, then crashed by 50.0% to $100000.0 in 2026.
  • Per Business Quant, the three most recent readings for BIO's Long-Term Debt Repayments are $100000.0 (Q1 2026), $200000.0 (Q4 2025), and $200000.0 (Q2 2025).